Last reviewed 2026-04-23 · How we verify

NAs

Nasacort is a corticosteroid that works by reducing inflammation in the nasal passages.

Nasacort is a corticosteroid that works by reducing inflammation in the nasal passages. Used for Seasonal allergic rhinitis, Perennial allergic rhinitis, Chronic idiopathic urticaria.

At a glance

Mechanism of action

Nasacort contains the active ingredient triamcinolone acetonide, which is a synthetic corticosteroid that is used to treat nasal congestion and sinus pressure associated with seasonal allergies and other conditions. It works by reducing inflammation in the nasal passages, which helps to relieve symptoms such as congestion, runny nose, and sneezing.

Approved indications

• Seasonal allergic rhinitis
• Perennial allergic rhinitis
• Chronic idiopathic urticaria

Common side effects

• Nasal dryness
• Nasal irritation
• Headache
• Cough
• Sore throat

Key clinical trials

• The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients (NA)
• MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome
• Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk Pregnant Women (NA)
• Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection (PHASE2)
• Cigarette Filter Study (NA)
• Treatment Education for Perinatal Women and Their Community Support (NA)
• Hepatic Energy Fluxes in NASH and NAS Patients (NA)
• Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE) (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.